NCT02299908

Brief Summary

Acute postoperative pain is one of the most important centers of therapeutic attention in postoperative phase of any procedure. It is a complex entity that requires a multiple intervention to be treated and, depending on the intervened surgical site, it has different approaches. Despite attempts to reduce postoperative pain by implementing management protocols, rates of pain prevalence from moderate acute to severe pain are still reported as high as 50% in the first 24 postoperative hours. Among the surgeries that report greater intensity of postoperative pain is open inguinal Herniorrhaphy. That is why several techniques have been described for the management of acute pain in this surgery postoperative, among which PAT blocking has shown to be beneficial in some studies. However, some reports question its usefulness but with the emergence of ultrasound-guided techniques for its realization, interest in this blockage has grown back. This study aims to demonstrate the utility of the PAT blocking in the management of acute pain of pre-peritoneal inguinal herniorrhaphy with mesh.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Nov 2014

Shorter than P25 for phase_4

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

November 17, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 24, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

November 24, 2014

Status Verified

November 1, 2014

Enrollment Period

8 months

First QC Date

November 17, 2014

Last Update Submit

November 20, 2014

Conditions

Keywords

Hernia, InguinalHerniorrhaphyAbdominal WallAnalgesiaPain, Postoperative

Outcome Measures

Primary Outcomes (1)

  • Postoperative acute pain measured by the visual analog scale (VAS) from 1-10 with 1 being the lowest and 10 the highest intensity after one hour of anesthesia suspension.

    1 hour after the suspension of anesthesia

Secondary Outcomes (5)

  • Opioid Consumption 1

    1 hour after the suspension of anesthesia

  • Adverse reactions 1

    1 hour after the suspension of anesthesia

  • Postoperative acute pain 2

    24 hours after the suspension of anesthesia

  • Adverse reactions 2

    24 hours after the suspension of anesthesia

  • Opioid Consumption 2

    24 hours after the suspension of anesthesia

Study Arms (2)

TAP block with Bupivacaine at 0.25%

EXPERIMENTAL

Intervention: Injection of local anesthetics in the transverses abdominal plane

Drug: TAP block with Bupivacaine at 0.25%

Placebo saline solution

PLACEBO COMPARATOR

Placebo: Injection of saline solution in the transverses abdominal plane

Drug: Placebo saline solution

Interventions

Application of 20 mL of local anesthetic bupivacaine at 0.25% in the transverse abdominis plane (TAP) under ultrasound guidance. This area (TAP) is between the anterior fascia of the transverse abdominal muscle and the posterior fascia of the internal oblique muscle, through which the thoracic nerve fibers and a portion of the first lumbar pass. This intervention will be done 10 minutes before conducting the ipsilateral inguinal herniorrhaphy in a single application.

Also known as: TAP block, Infiltration of local anesthetic, Local anesthesia in inguinal herniorrhaphy
TAP block with Bupivacaine at 0.25%

Application of 20 mL of saline solution in the transverse abdominis plane (TAP).

Also known as: Saline solution
Placebo saline solution

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years attending Servicios Especiales de Salud (SES) Hospital of Caldas and Santa Sofia Hospital for inguinal hernia surgery.
  • Physical status classification of the American Society of Anesthesiologists (ASA) (ASA I: healthy patient with no history or comorbidity and ASA II patients with compensated systemic disease).
  • Acceptance to complete the informed consent.

You may not qualify if:

  • Bilateral inguinal hernia.
  • Allergy to drugs used in the study protocol (propofol, remifentanil, dipyrone, Dexamethasone, Tramadol, Morphine, Bupivacaine, Cephalexin, Cefazolin, Lidocaine, Sevoflurane, Chlorhexidine, Adrenaline, Naproxen, Acetaminophen)
  • Lack of communication with the patient
  • Inadequate social support network and interaction with the physician.
  • Spinal Anesthesia
  • Herniorrhaphy without mesh.
  • Pregnancy
  • Abuse of psychoactive substances.
  • Daily consumption of opioids.
  • Consumption of analgesics during the last 24 hours prior to surgery.
  • Infection at the incision site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hospital Departamental Universitario Santa Sofía de Caldas

Manizales, Caldas Department, 170001, Colombia

Location

SES Hospital de Caldas

Manizales, Caldas Department, 170001, Colombia

Location

MeSH Terms

Conditions

Pain, PostoperativeHernia, InguinalAgnosia

Interventions

Anesthesia, LocalSaline Solution

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsHernia, AbdominalHerniaPathological Conditions, AnatomicalPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and AnalgesiaCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Oscar D Aguirre Ospina, Specialist

    Universidad de Caldas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Patricia Salazar Villegas, Mg.

CONTACT

Juan C Gómez Salgado, Specialist

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Master in Business Administration

Study Record Dates

First Submitted

November 17, 2014

First Posted

November 24, 2014

Study Start

November 1, 2014

Primary Completion

July 1, 2015

Study Completion

October 1, 2015

Last Updated

November 24, 2014

Record last verified: 2014-11

Locations